Literature DB >> 21901321

Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.

Morgane Besson1, Vincent David, Mathieu Baudonnat, Pierre Cazala, Jean-Philippe Guilloux, Christelle Reperant, Isabelle Cloez-Tayarani, Jean-Pierre Changeux, Alain M Gardier, Sylvie Granon.   

Abstract

RATIONALE: Nicotine is the main addictive component of tobacco and modifies brain function via its action on neuronal acetylcholine nicotinic receptors (nAChRs). The mesolimbic dopamine (DA) system, where neurons of the ventral tegmental area (VTA) project to the nucleus accumbens (ACb), is considered a core site for the processing of nicotine's reinforcing properties. However, the precise subtypes of nAChRs that mediate the rewarding properties of nicotine and that contribute to the development of addiction remain to be identified.
OBJECTIVES: We investigated the role of the nAChRs containing the α7 nicotinic subunit (α7 nAChRs) in the reinforcing properties of nicotine within the VTA and in the nicotine-induced changes in ACb DA outflow in vivo.
METHODS: We performed intra-VTA self-administration and microdialysis experiments in genetically modified mice lacking the α7 nicotinic subunit or after pharmacological blockade of α7 nAChRs in wild-type mice.
RESULTS: We show that the reinforcing properties of nicotine within the VTA are lower in the absence or after pharmacological blockade of α7 nAChRs. We also report that nicotine-induced increases in ACb DA extracellular levels last longer in the absence of these receptors, suggesting that α7 nAChRs regulate the action of nicotine on DA levels over time.
CONCLUSIONS: The present results reveal new insights for the role of α7 nAChRs in modulating the action of nicotine within the mesolimbic circuit. These receptors appear to potentiate the reinforcing action of nicotine administered into the VTA while regulating its action over time on DA outflow in the ACb.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901321     DOI: 10.1007/s00213-011-2422-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  71 in total

Review 1.  Central nicotinic receptors, neurotrophic factors and neuroprotection.

Authors:  N Belluardo; G Mudò; M Blum; K Fuxe
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

2.  Long-term effects of chronic nicotine exposure on brain nicotinic receptors.

Authors:  Morgane Besson; Sylvie Granon; Monica Mameli-Engvall; Isabelle Cloëz-Tayarani; Nicolas Maubourguet; Anne Cormier; Pierre Cazala; Vincent David; Jean-Pierre Changeux; Philippe Faure
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

3.  Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens.

Authors:  Laurie H L Sellings; Golriz Baharnouri; Lindsey E McQuade; Paul B S Clarke
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

4.  5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex.

Authors:  I Malagié; A C Trillat; M Bourin; C Jacquot; R Hen; A M Gardier
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

5.  Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.

Authors:  Ainhoa Plaza-Zabala; Elena Martín-García; Luis de Lecea; Rafael Maldonado; Fernando Berrendero
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

6.  Differential region-specific regulation of α4β2* nAChRs by self-administered and non-contingent nicotine in C57BL/6J mice.

Authors:  Athanasios Metaxas; Alexis Bailey; Maria Flavia Barbano; Lola Galeote; Rafael Maldonado; Ian Kitchen
Journal:  Addict Biol       Date:  2010-08-23       Impact factor: 4.280

7.  Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area.

Authors:  Satoshi Ikemoto; Mei Qin; Zhong-Hua Liu
Journal:  J Neurosci       Date:  2006-01-18       Impact factor: 6.167

8.  Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.

Authors:  A J Grottick; G Trube; W A Corrigall; J Huwyler; P Malherbe; R Wyler; G A Higgins
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

Review 9.  The scientific case that nicotine is addictive.

Authors:  I P Stolerman; M J Jarvis
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

10.  Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists.

Authors:  Sheri D Grabus; Billy R Martin; Sharon E Brown; M Imad Damaj
Journal:  Psychopharmacology (Berl)       Date:  2006-02-04       Impact factor: 4.530

View more
  25 in total

Review 1.  Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions.

Authors:  Dympna Harmey; Patrick R Griffin; Paul J Kenny
Journal:  Nicotine Tob Res       Date:  2012-09-27       Impact factor: 4.244

Review 2.  Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability.

Authors:  Christie D Fowler; Paul J Kenny
Journal:  Neuropharmacology       Date:  2013-09-18       Impact factor: 5.250

Review 3.  Unraveling the neurobiology of nicotine dependence using genetically engineered mice.

Authors:  Astrid K Stoker; Athina Markou
Journal:  Curr Opin Neurobiol       Date:  2013-03-29       Impact factor: 6.627

4.  Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.

Authors:  Xiu Liu
Journal:  Int J Neuropsychopharmacol       Date:  2013-08-19       Impact factor: 5.176

5.  Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice.

Authors:  J L Harenza; P P Muldoon; M De Biasi; M I Damaj; M F Miles
Journal:  Genes Brain Behav       Date:  2013-12-26       Impact factor: 3.449

6.  Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.

Authors:  Xiu Liu
Journal:  Psychopharmacology (Berl)       Date:  2013-05-28       Impact factor: 4.530

7.  Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.

Authors:  Andrew C Meyer; Nichole M Neugebauer; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  J Neurochem       Date:  2013-08-20       Impact factor: 5.372

8.  Nicotinic receptor contributions to smoking: insights from human studies and animal models.

Authors:  Darlene H Brunzell; Alexandra M Stafford; Claire I Dixon
Journal:  Curr Addict Rep       Date:  2015-03

Review 9.  Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.

Authors:  Darlene H Brunzell; J Michael McIntosh; Roger L Papke
Journal:  Ann N Y Acad Sci       Date:  2014-04-14       Impact factor: 5.691

Review 10.  A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders.

Authors:  Kenneth Grasing
Journal:  Behav Brain Res       Date:  2016-06-15       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.